White label ELPA - ClinicalTrials.eu

Study on Pembrolizumab and Cyclophosphamide for Patients with Metastatic Urothelial Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Transitional cell carcinoma
Investigated drugs:
- Cyclophosphamide Monohydrate
Study on How N-acetylcysteine Helps Treat Cannabis Addiction in Adults

Not recruiting

3 1 1
Investigated diseases:
- Drug dependence
Investigated drugs:
- Acetylcysteine
Study on the Safety and Effectiveness of Alpha1H for Adults with Non-Muscle Invasive Bladder Cancer Awaiting Tumor Removal Surgery

Not recruiting

1 1
Investigated diseases:
- Bladder transitional cell carcinoma
Investigated drugs:
- Alpha1H
Study of CD19-CAR_Lenti, Fludarabine, and Cyclophosphamide in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia or Aggressive B-Cell Lymphomas

Not recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
Study on the Effectiveness of Cup a 1 Immunotherapy for Patients with Moderate to Severe Allergic Rhinoconjunctivitis with or without Controlled Asthma

Not recruiting

3 1
Investigated diseases:
- Conjunctivitis allergic
Study of Quizartinib with Chemotherapy for Adults with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia

Not recruiting

3 1 1
Investigated drugs:
+9
Study on the Use of 18F-PSMA-1007, Piflufolastat (18F), and Gozetotide for Detecting Pelvic Lymph Node Invasion in Newly Diagnosed Prostate Cancer Patients

Not recruiting

3 1 1 1
Investigated diseases:
- Prostate cancer
Investigated drugs:
Study on Verapamil SR for Adults with Newly Diagnosed Type 1 Diabetes to Preserve Beta-Cell Function

Not recruiting

2 1 1
Investigated diseases:
- Type 1 diabetes mellitus
Investigated drugs:
- Verapamil Hydrochloride
Study Comparing Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan for Patients with Advanced Prostate Cancer

Not recruiting

1 1 1 1
Investigated diseases:
- Hormone-refractory prostate cancer
Investigated drugs:
- Lutetium (177Lu) Vipivotide Tetraxetan
- 177Lu-Rhpsma-10.1
Study on the Safety and Effectiveness of Sargramostim with Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethasone in Untreated Light Chain Amyloidosis Patients

Not recruiting

2 1 1 1
Investigated diseases:
- Primary amyloidosis
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies